Angiodynamics (ANGO) EBT Margin (2016 - 2025)
Historic EBT Margin for Angiodynamics (ANGO) over the last 17 years, with Q4 2025 value amounting to 8.0%.
- Angiodynamics' EBT Margin rose 68900.0% to 8.0% in Q4 2025 from the same period last year, while for Nov 2025 it was 9.02%, marking a year-over-year increase of 738400.0%. This contributed to the annual value of 11.63% for FY2025, which is 514200.0% up from last year.
- Latest data reveals that Angiodynamics reported EBT Margin of 8.0% as of Q4 2025, which was up 68900.0% from 14.31% recorded in Q3 2025.
- Over the past 5 years, Angiodynamics' EBT Margin peaked at 44.31% during Q3 2023, and registered a low of 265.68% during Q1 2024.
- In the last 5 years, Angiodynamics' EBT Margin had a median value of 11.65% in 2021 and averaged 23.14%.
- Per our database at Business Quant, Angiodynamics' EBT Margin tumbled by -2537000bps in 2024 and then skyrocketed by 2595500bps in 2025.
- Quarter analysis of 5 years shows Angiodynamics' EBT Margin stood at 11.32% in 2021, then rose by 6bps to 10.59% in 2022, then crashed by -51bps to 15.96% in 2023, then grew by 7bps to 14.89% in 2024, then soared by 46bps to 8.0% in 2025.
- Its EBT Margin stands at 8.0% for Q4 2025, versus 14.31% for Q3 2025 and 7.62% for Q2 2025.